Abstract:Enzymatic asymmetric sulfoxidation using molecular oxygen as the oxidant is a promising green chemistry approach to chiral sulfoxide production. Despite the broad substrate spectrum of cyclohexanone monooxygenases (CHMOs), some unnatural substrates with bulky functional groups, such as the pharmaceutically relevant omeprazole sulfide, cannot be effectively accepted by CHMOs. Herein, we describe a set of variants derived from an Acinetobacter calcoaceticus CHMO (AcCHMO), whose active sites adjacent to the substrate tunnel were altered to shift the substrate specificity from cyclohexanone monooxygenation toward omeprazole sulfide sulfoxidation. We performed homologous modeling and molecular docking to identify key residues that might affect the substrate specificity. Two libraries of residues lining the active center of AcCHMO were then constructed and screened by an effective halo-based selection method using the solubility difference between the substrate (omeprazole sulfide) and product (esomeprazole). Functional evaluation of the resultant variants showed that the substrate specificity of AcCHMO was markedly altered from the small natural substrate (cyclohexanone) toward the desired bulky substrate (omeprazole sulfide) despite the extremely poor activity detected even for the best variant, M2 (0.61 U/g(prot)). The crystal structure of M2 complexed with a flavin adenine dinucleotide (FAD) prosthetic group was determined, which provided insight into the altered substrate specificity. To improve the activity of enzyme M2 toward pharmaceutical precursor omeprazole sulfide, we performed both local and global protein engineering among the two CASTing libraries surrounding FAD(+) and NADP(+) prosthetic groups and an error-prone PCR library of the full-length AcCHMO. As a result, variant M6 was obtained, giving a 50-fold higher activity compared to M2. This structure-guided protein engineering of AcCHMO provided a promising candidate for converting omeprazole sulfide into (S)-omeprazole using a green biocatalytic method.

Synthesis of Esomeprazole Catalyzed by Immobilized Cells

Asymmetric Bio-oxidation Using Resting Cells of Rhodococcus rhodochrous ATCC 4276 Mutant QZ-3 for Preparation of ( S )-Omeprazole in a Chloroform–Water Biphasic System Using Response Surface Methodology

Development of Whole Cell Biocatalytic System for Asymmetric Synthesis of Esomeprazole with Enhancing Coenzyme Biosynthesis Pathway

Novel process for omeprazole synthesis

“Nonpolarity Paving” in Substrate Tunnel of a Limnobacter Sp. Phenylacetone Monooxygenase for Efficient Single Whole-Cell Synthesis of Esomeprazole

Enzymatic Preparation Of The Chiral (S)-Sulfoxide Drug Esomeprazole At Pilot-Scale Levels

Preparation Of Coated Cellulose Triphenylcarbamate Chiral Stationary Phase For The Resolution Of Omeprazole

Continuous Flow Synthesis of Esomeprazole via Asymmetric Sulfoxidation

Engineering of Cyclohexanone Monooxygenase for the Enantioselective Synthesis of (S)-Omeprazole

Synthesis of Esomeprazole Sodium

An Efficient Silica Supported Chitosan@vanadium Catalyst for Asymmetric Sulfoxidation and Its Application in the Synthesis of Esomeprazole

Catalytic Asymmetric Synthesis of Esomeprazole by a Titanium Complex with a Hexa-aza-triphenolic Macrocycle Ligand

Asymmetric Sulfoxidation of Thioether Catalyzed by Soybean Pod Shell Peroxidase to Form Enantiopure Sulfoxide in Water-in-Oil Microemulsions: A Kinetic Model

Secretory Expression of Cyclohexanone Monooxygenase by Methylotrophic Yeast for Efficient Omeprazole Sulfide Bio-Oxidation

Synthesis and Resolution of Omeprazole

Protein engineering of thioether monooxygenase to improve its thermostability for enzymatic synthesis of chiral sulfoxide

Improved Enantioselectivity of E. Coli BioH in Kinetic Resolution of Methyl (S)-3-cyclohexene-1-carboxylate by Combinatorial Modulation of Steric and Aromatic Interactions

Enzyme-catalyzed Asymmetric Synthesis of Optically Active (R)- and (S)-Ethyl -4-phenyl-4-hydroxybutyrate with Microbial Cells

Chemo-enzymatic Asymmetric Synthesis of S-citalopram by Lipase-Catalyzed Cyclic Resolution and Stereoinversion of Quaternary Stereogenic Center.

Enzymatic synthesis of pharmacologically relevant chiral sulfoxides by improved <i>Cb</i>BVMO variants

Synthesis of Esomeprazole Magnesium